A Open-label Phase I Study to Evaluate Safety of a Sabin Inactivated Poliovirus Vaccine (sIPV) in Adults, Children, and Infants, and a Blinded, Randomized and Controlled Phase II to Evaluate Safety and Immunogenicity of it in Infants

Trial Profile

A Open-label Phase I Study to Evaluate Safety of a Sabin Inactivated Poliovirus Vaccine (sIPV) in Adults, Children, and Infants, and a Blinded, Randomized and Controlled Phase II to Evaluate Safety and Immunogenicity of it in Infants

Completed
Phase of Trial: Phase I/II

Latest Information Update: 29 Jul 2017

At a glance

  • Drugs Poliovirus vaccine Intravacc/WHO (Primary) ; Poliovirus vaccine inactivated
  • Indications Poliomyelitis
  • Focus Pharmacodynamics
  • Sponsors Sinovac Biotech
  • Most Recent Events

    • 25 Jul 2017 Status changed from recruiting to completed.
    • 01 May 2017 Planned primary completion date changed from 1 Jan 2017 to 1 Jun 2017.
    • 12 Dec 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top